12:00 AM
 | 
Jun 12, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Morphelan once daily solid oral formulation of morphine regulatory update

ELN submitted an NDA to the FDA for its Morphelan capsules to manage pain in oncology and HIV-positive patients. Under a 1998 licensing agreement with...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >